Inmaculada Hernandez is an associate professor at the University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. She has published more than 80 peer-reviewed scientific manuscripts in high-impact journals and her research has been featured in main news media outlets.
Hernandez has extensively studied the underuse of anticoagulation in stroke prevention for patients with cardiac arrhythmias. She recently received an R01 award from the National Institutes of Health to study the impact of the COVID-19 pandemic on patients with cardiovascular disease. She has also made important
contributions to the study of pharmaceutical pricing. In 2020, she was the first to quantify the role of manufacturer discounts in rising drug prices. During the past year, Hernandez led a group of investigators evaluating geographic access to COVID-19 vaccine administration locations. Their analyses informed the Pennsylvania Department of Health’s distribution of COVID-19 vaccines in
medically underserved areas.
In 2021, Hernandez became the first pharmacist and first Hispanic to receive the Academy Health Alice S. Hersh Emerging Leader Award. She is a Fellow of the American College of Cardiology and the American Heart Association.
Hernandez earned her MS in health economics and pharmacoeconomics from Pompeu Fabra University (Spain) and her PharmD from the University of Navarra (Spain). While at Pitt Public Health, she earned her PhD in health services research and policy.